Spring’s AI R&D platform was acquired by a major biotech leader in the Bay Area.
We are proud to continue serving brilliant researchers and thank our supporters, partners, new home, and teammates for working together to give scientists AI superpowers.
1/ The last time you heard from me about Spring Science, we were going to wind down. Then a really cool thing happened.
I am proud to share that Spring’s AI R&D platform has been acquired by a major biotech leader in the Bay Area*, where it will serve more scientists than ever before.
have an incredible immunologist now looking for next thing due to this —
strong startup experience, drug discovery project leader, and AI+drug discovery veteran
DM me for more
1/ Spring’s AI tools are loved by scientists. But we do not make enough money to continue running the company.
Our tech gives ground-breaking new superpowers to researchers and has helped therapeutics groups around the world, from big pharma to biotech to rare disease orgs to academia.
At the same time, we’ve struggled to find a business model that can support our operations. We’ve made the difficult decision to wind down.
We know the closure of Spring leaves a major gap in the market. We’re currently having many discussions about ways for our platform’s impact to live on. I’m entertaining ideas here, more at the end.
❗ Beware of 'AI-washed' products in drug discovery and data analysis!❗
True innovation isn't about slapping an AI label on old tech. The Spring Engine represents genuine AI advancement, accelerating drug discovery like never before.
At Spring Discovery, we're not just using AI – we're redefining it for drug discovery.
Our cutting-edge embeddings technology is years ahead of the competition. Discover how we're revolutionizing image analysis: https://t.co/YBWgcntdEl
#AIInnovation#DrugDiscovery
🎃 Not all cells go quietly… ☠️ Some die with a bang, others with a whimper, and Spring’s AI tools capture every haunting detail. Let’s dive into the eerie world of cell death mechanisms. (1/4)
🔍 Spring’s AI tools surface these pathways, making it easier than ever for scientists to understand the mysteries of cell fate — no magic required! 🧙♀️
So this Halloween, let’s get spooky with science. May your assays be as haunting as they are illuminating! 🌙💀 (3/4)
@unicampoficial@broadinstitute@SaguaroBio 6/ Learn more about how we’re adopting these methods and our work on live-cell and label-free analysis approaches. Check out our latest blog here: 🔗 https://t.co/yfN0H1TF30
Stay tuned for more exciting updates from @SpringScienceAI! 👀
#LifeSciences#DrugDiscovery
1/ 🔬 Exciting research from @unicampoficial@broadinstitute introduces Live Cell Painting—a novel imaging method using Acridine Orange to assess cell health in real-time.
This breakthrough allows observation of live cells, giving deeper insights into cellular responses.
@unicampoficial@broadinstitute@SaguaroBio 5/ Combining Live Cell Painting with our platforms could help us better identify drug candidates & understand complex biological mechanisms. This kind of innovation is key to developing life-saving treatments.
#AI#DrugDevelopment#Biotech
What complex tasks can a model complete? And in what environment (available tools, quality thereof)? What constraints (wall clock time, inference costs)? Eval continues to get more complex, but again, that's what we'd expect when something new is on horizon...
Props to Anthropic for shipping computer use. Very exciting. I'm seeing lots of interesting example use cases and also a lot of "failures" where the model ultimately can't finish the task.
...but that's maybe what you'd expect when you open a door to something new + important!
We love cute animal pictures as much as the next person, but they won’t help us discover new therapies. We use real cell imaging data for that! 🧬🐱🐶
#BioEmbeddings#AI#NotYourAverageAI
Our AI platform analyzes vast biological data, uncovering insights that could take traditional methods decades to find. The future of medicine is here, driven by AI. Stay tuned! #AI#DrugDiscovery#TechBio
At Spring Science, we're using specialized AI to revolutionize drug discovery—accelerating the development of life-changing treatments by compressing years of progress into a fraction of the time.